Skip to main content

Home/ Jacob Solomon's group - M2015(B)/ Group items tagged Drugs

Rss Feed Group items tagged

Aleksi B

India Plans Price Controls on Patented Drugs - WSJ.com - 0 views

  • India plans to widen the scope of price controls on pharmaceuticals
  • The new proposals would extend price restrictions beyond generic medicines to apply for the first time to patented drugs
  • The plans come as Bayer AG BAYN.XE -0.17% Bayer AG Germany: Xetra €94.89 -0.16 -0.17% Nov. 15, 2013 5:35 pm Volume : 2.67M P/E Ratio 25.24 Market Cap €78.47 Billion Dividend Yield 2.00% Rev. per Employee €363,176 10/31/13 Bayer Boosted by New Drugs 09/13/13 Bayer Under Scrutiny in China More quote details and news » BAYN.XE in Your Value Your Change Short position is fighting an order from India's patent authority that required the Germany company to issue a license allowing an Indian generic-drug company to sell a less expensive copy of Bayer's patented cancer drug Nexavar.
  • ...3 more annotations...
  • India sets prices for 74 generic medicines and is considering increasing the number of medicines covered by price caps to 348
  • Any attempt to restrict prices of patented drugs likely will rankle foreign pharmaceutical companies
  • The move raised fears in India that without price controls patented drugs might be unaffordable for a majority of the country's 1.2 billion people.
  •  
    The article explains on how India are planning to put price controls on their drugs making them go for lower prices so that people can afford them.
Aleksi B

Department of Pharmaceuticals seeks Law Ministry opinion on drug pricing mechanism issu... - 0 views

  •  
    Drugs are raising in price due to price mechanism, now the government might start getting involved and lowering prices to some drugs
Hardy Hewson

WikiLeaks' free trade documents reveal 'drastic' Australian concessions - 0 views

  •  
    Secret negotiations over the Trans Pacific Partnership (TPP) free trade agreement have apparently been breached by another leak of material which shows Australian consumers could pay more for cancer medicines and face criminal penalties for non-commercial copyright breaches.
  •  
    The article concerns the recent reveal by WikiLeaks of free-trade agreements between the nations of the Trans-Pacific Partnership (members include the United States, Japan, Australia and Singapore). The article states that Australia has made considerable concessions to nations such as Japan and the US by permitting increases in regulation over intellectual property, specifically for cancer related drugs. The new regulation could mean that government permitted monopolies could be extended, meaning patients may be forced to pay more for treatment for longer periods of time.
1 - 3 of 3
Showing 20 items per page